Gary Mather
- Virology top 5%
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism 5
- Psychiatry and Mental health top 5%
- Epilepsy research and treatment 5
-
- Pharmacological Effects and Toxicity Studies 5
- Organic Chemistry top 5%
- Synthesis and Characterization of Heterocyclic Compounds 3
-
- Drug Transport and Resistance Mechanisms 4
- Metal complexes synthesis and properties 4
- Cancer Treatment and Pharmacology 4
-
- Biochemical and Molecular Research 3
Gary Mather
35 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 96
- Virology 97
- Pharmacology 160
- Psychiatry and Mental health 240
- Pediatrics, Perinatology and Child Health 250
- Organic Chemistry 354
Countries citing papers authored by Gary Mather
This map shows the geographic impact of Gary Mather's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary Mather with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary Mather more than expected).
Fields of papers citing papers by Gary Mather
This network shows the impact of papers produced by Gary Mather. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary Mather. The network helps show where Gary Mather may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Gary Mather, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 1 | |
| 2 | 2010 | 44 | |
| 3 | 2007 | 94 | |
| 4 | MPC-6827, a small molecule inhibitor of microtubule formation with high brain penetration: absorption, distribution, metabolism, excretion, and clinical considerations | 2005 | 5 |
| 5 | 2004 | 28 | |
| 6 | 2002 | 50 | |
| 7 | 2000 | 28 | |
| 8 | 1999 | 93 | |
| 9 | 1997 | 89 | |
| 10 | 1997 | 44 | |
| 11 | 1997 | 12 | |
| 12 | 1996 | 28 | |
| 13 | 1994 | 15 | |
| 14 | 1991 | 7 | |
| 15 | 1991 | 3 | |
| 16 | 1990 | 9 | |
| 17 | 1990 | 50 | |
| 18 | 1973 | 72 | |
| 19 | 1973 | 18 | |
| 20 | 1973 | 27 |
About Gary Mather
Gary Mather is a scholar working on Pharmacology, Oncology and Inorganic Chemistry, having authored 36 papers that have together received 1.3k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (5 papers), Epilepsy research and treatment (5 papers), Pharmacological Effects and Toxicity Studies (5 papers), Drug Transport and Resistance Mechanisms (4 papers), Metal complexes synthesis and properties (4 papers), Cancer Treatment and Pharmacology (4 papers), Synthesis and Characterization of Heterocyclic Compounds (3 papers) and Biochemical and Molecular Research (3 papers). The work is most often cited by research in Virology (97 citations), Pharmacology (160 citations) and Psychiatry and Mental health (240 citations). Gary Mather has collaborated with scholars based in United States, Belgium and Israel. Frequent co-authors include René H. Levy, Alan Pidcock, W. Trager, James J. Keirns, David A. Erickson, Jerry H. Exon, Jeanine L. Bussiere, Loren D. Koller, William Trager and Mark Anderson. Their work appears in journals such as Molecular Cancer Therapeutics, Journal of Clinical Oncology, Cancer Research, Immunobiology and Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.